The Danger That Grows in Silence

A middle-aged man with gray hair and a beard, wearing a navy blue sweater and khaki pants, appears to be in pain or discomfort while holding onto a staircase railing in a modern living room near the beach.

Heart failure doesn’t arrive with a warning.

For millions of people, it builds quietly over months — subtle changes in the heart that no one can feel, see, or measure at home. By the time symptoms appear, the damage is already done, and the window for early intervention has closed.

But what if silence didn’t have to mean uncertainty?

What if those invisible signals could be captured clearly and effortlessly, long before they become dangerous?

That’s exactly where the breakthrough begins.

Heart failure affects more than 50 million people worldwide and remains one of the leading causes of hospitalization and death, growing by over 10% every year.

Beyond those already diagnosed, 15% of people over 65 are silently at risk — often without knowing it.

Yet despite major advances in medicine, detection is still reactive, not preventive. Most patients are diagnosed only after irreversible damage has already occurred. Implantable monitors are invasive and costly, while skin-patch wearables struggle with comfort, acceptance, and long-term adherence.

The result is a critical gap: clinicians have no accessible way to detect heart failure decompensation early - when earlier intervention could make a meaningful difference.

Funding

Funding History

Co-founders’ personal investment - fully funding R&D, prototyping, and preclinical validation.

In-kind contributions from clinical and academic partners - early validation support and research collaboration.

TAM > $12B - 50M+ patients

〰️

TAM > $12B - 50M+ patients 〰️

Funding needs

After two years of development, the prototype has reached its second version and full technical maturity. It is now ready for industrialization and for the launch of international clinical validation studies.

KardioVis is actively engaging pre-seed and seed investors to complete this final stage and support the pathway toward market entry.

A family of five running and playing on the beach, smiling and enjoying a sunny day.

Join us in redefining heart failure care!

Contact Us